(R)-6-氨基-1,4-THIAZEPAN-5-酮 | 92814-42-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: (R)-6-氨基-1,4-THIAZEPAN-5-酮
• 中文别名: (R)-6-氨基-1,4-硫氮杂-5-环庚酮
• 英文名称: (6R)-6-aminotetrahydro-1,4-thioazepin-5(2H)-one
• 英文别名: (R)-6-amino-[1,4]thiazepan-5-one；(R)-6-Amino-1,4-thiazepan-5-one；(6R)-6-amino-1,4-thiazepan-5-one
• CAS: 92814-42-1
• 化学式: C₅H₁₀N₂OS
• mdl: MFCD10566767
• 分子量: 146.213
• InChiKey: NGIAYEBFKTVVQJ-BYPYZUCNSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.9
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  80.4
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2934999090

反应信息

• 作为反应物：
  描述：

  (R)-6-氨基-1,4-THIAZEPAN-5-酮 在 双(三甲基硅烷基)氨基钾 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 生成 ((R)-6-tert-butoxycarbonylamino-5-oxo-[1,4]thiazepa-4-yl)-acetic acid ethyl ester
  参考文献：
  名称：

  Synthesis and evaluation of thiazepines as interleukin-1β converting enzyme (ICE) inhibitors

  摘要：

  A series of monocyclic thiazepine inhibitors of interleukin-1 beta converting enzyme (ICE) were synthesized in eight steps from commercially available intermediates. In vitro biological evaluation showed the thiazepines to be moderately potent ICE inhibitors, with the most active compound exhibiting an IC50 value of 30 nM in an enzyme inhibition assay. Compounds of this class possessed good selectivity against the related enzymes caspase-3 and caspase-8. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.07.016
• 作为产物：
  描述：

  美司坦 、 2-氯乙胺盐酸盐 生成 (R)-6-氨基-1,4-THIAZEPAN-5-酮
  参考文献：
  名称：

  [EN] DERIVATIVES OF AZEPINE AND THIAZERAN AS INTERLEUKIN CONVERTING ENZYME INHIBITORS
  [FR] DERIVES D'AZEPINE ET DE THIAZERAN UTILISES COMME INHIBITEURS DE ENZYME DE CONVERSION DE L'INTERLEUKINE

  摘要：

  本发明涉及公式I的白细胞介素-Iβ转化酶抑制剂，其中每个X独立地从以下选项中选择：i) -C(W)2-；ii) -C(O)-；iii) -NR2-；iv) -S-；v) -S(O)-；vi) -S(O)2-；vii) 两个单位，每个单位来自相邻的X单位，可以结合在一起形成具有公式 -CW=WC- 的取代或未取代的双键；其中每个W是具有公式 -(L2)j-R2 的单位的氢，指数j为0或1；R是一个碳环或杂环芳基环；R1是一个半胱氨酸陷阱；每个R2独立地是一个合适的取代基；L、L1和L2是连接单元。

  公开号：

  WO2003103677A1

文献信息

• [EN] SUBSTITUTED QUINOLINE CCR5 RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DU RECEPTEUR CCR5 A BASE DE QUINOLEINE SUBSTITUES
  申请人：SCHERING AG

  公开号：WO2004002960A1

  公开（公告）日：2004-01-08

  The present invention relates to CCR5 receptor antagonists of formulae (1a) or (1b), enantiomers, diastereomers, salts and solvates thereof wherein R1, R2, R3, R4, R5, and R7 are as defined herein. The invention further includes a method of CCR5-mediated disorders employing such compounds.

  本发明涉及式（1a）或（1b）的CCR5受体拮抗剂，其对映体、二对映体、盐和溶剂合物，其中R1、R2、R3、R4、R5和R7如本文所定义。该发明还包括一种利用这些化合物治疗CCR5介导的疾病的方法。
• Discovery of Thioazepinone Ligands for Src SH2: From Non-specific to Specific Binding
  作者：Dominique Lesuisse、Pierre Deprez、Eva Albert、Tran Thien Duc、Benoit Sortais、Dominique Gofflo、Véronique Jean-Baptiste、Jean-Pierre Marquette、Bernard Schoot、Edoardo Sarubbi、Gudrun Lange、Pierre Broto、Eliane Mandine

  DOI：10.1016/s0960-894x(01)00386-9

  日期：2001.8

  The structure-based design and synthesis of new thioazepinones as ligands for Src SH2 protein is presented. From benzothioazepinones, ligands with somewhat unspecific binding properties, simpler thioazepinones were designed, the best ones demonstrated nanomolar affinity for Src SH2. A few of these new ligands were crystallized with the protein and demonstrated a specific binding mode with the protein. (C) 2001 Elsevier Science Ltd. All rights reserved.
• [EN] DERIVATIVES OF AZEPINE AND THIAZERAN AS INTERLEUKIN CONVERTING ENZYME INHIBITORS<br/>[FR] DERIVES D'AZEPINE ET DE THIAZERAN UTILISES COMME INHIBITEURS DE ENZYME DE CONVERSION DE L'INTERLEUKINE
  申请人：PROCTER & GAMBLE

  公开号：WO2003103677A1

  公开（公告）日：2003-12-18

  The present invention relates to interleukin - Iβ converting enzyme inhibitors of formula I: wherein each X is independently selected from: i) -C(W)2-; ii) -C(O)-; iii) -NR2-; iv) -S-; v) -S(O)-; vi) -S(O)2-; vii) two units, one from each adjacent X unit, can be taken together to form a substituted or unsubstituted double bond having the formula -CW=CW-; wherein each W is hydrogen of a unit having the formula -(L2)j-R2, the index j is 0 or 1;R is a carbocyclic or heterocyclic aryl ring; R1 is a cysteine trap; each R2 is independently a suitable substituent; and L, L1, and L2 are linking units.

  本发明涉及公式I的白细胞介素-Iβ转化酶抑制剂，其中每个X独立地从以下选项中选择：i) -C(W)2-；ii) -C(O)-；iii) -NR2-；iv) -S-；v) -S(O)-；vi) -S(O)2-；vii) 两个单位，每个单位来自相邻的X单位，可以结合在一起形成具有公式 -CW=WC- 的取代或未取代的双键；其中每个W是具有公式 -(L2)j-R2 的单位的氢，指数j为0或1；R是一个碳环或杂环芳基环；R1是一个半胱氨酸陷阱；每个R2独立地是一个合适的取代基；L、L1和L2是连接单元。
• Synthesis and evaluation of thiazepines as interleukin-1β converting enzyme (ICE) inhibitors
  作者：Christopher D. Ellis、Kofi A. Oppong、Michael C. Laufersweiler、Steven V. O’Neil、David L. Soper、Yili Wang、John A. Wos、Amy N. Fancher、Wei Lu、Maureen K. Suchanek、Richard L. Wang、Biswanath De、Thomas P. Demuth

  DOI：10.1016/j.bmcl.2006.07.016

  日期：2006.9

  A series of monocyclic thiazepine inhibitors of interleukin-1 beta converting enzyme (ICE) were synthesized in eight steps from commercially available intermediates. In vitro biological evaluation showed the thiazepines to be moderately potent ICE inhibitors, with the most active compound exhibiting an IC50 value of 30 nM in an enzyme inhibition assay. Compounds of this class possessed good selectivity against the related enzymes caspase-3 and caspase-8. (c) 2006 Elsevier Ltd. All rights reserved.